Abstract: Provided are wound sealer components, comprising: an upper surface, a bottom surface, a vacuum chamber defined between the upper surface and the lower surface, the bottom surface defining at least one vacuum chamber opening in fluid communication with the vacuum chamber, and the vacuum chamber opening being defined between vacuum chamber opening edges of the component; a vacuum tap that places the vacuum chamber into fluid communication with the environment exterior to the vacuum tap, the vacuum tap being adapted for application of vacuum within the vacuum chamber, the at least one vacuum chamber opening being adapted to, upon application of sufficient vacuum from the tap, securably engage with tissue proximate to the bottom surface by drawing at least some of the tissue toward or even into the vacuum chamber so as to stably affix the component to the tissue, and a sealer portion, the sealer portion configured such that application of vacuum to draw tissue toward or even into the vacuum chamber exerts the sea

Abstract: Using whole blood viscosity (WBV) data collected at various shear rates in conjunction with other clinically relevant information—such as age, gender, and other medical history information—one can generate information indicative of a current or physiological condition of a subject. Such generation can be accomplished using machine learning, such as a trained algorithm. One can also train an algorithm using WBV and other clinically relevant information. The described approaches allow for early detection and treatment of conditions, such as sepsis, as well as the evaluation of a treatment or treatments administered to a patient in need.

Abstract: Provided are apparatuses and methods for rapid viscometry of whole blood, plasma, and/or whole blood during coagulation. The disclosed technology measures the blood viscosity through the full range of flow rates found in the cardio-vascular system. This in vitro test can be performed on fresh or anticoagulated whole blood to predict the flow properties (e.g., viscosity) anywhere in the body from the aorta to the deep veins of the leg. The result is a flow-rate dependent blood viscosity curve (viscosity profile) that helps the clinician predict and manage the patient's vulnerability to thrombosis and embolism, which is of particular relevance to COVID-19 patients and/or ICU patients.

Abstract: Provided are apparatuses and methods for rapid viscometry of whole blood, plasma, and/or whole blood during coagulation. The disclosed technology measures the blood viscosity through the full range of flow rates found in the cardio-vascular system. This in vitro test can be performed on fresh or anticoagulated whole blood to predict the flow properties (e.g., viscosity) anywhere in the body from the aorta to the deep veins of the leg. The result is a flow-rate dependent blood viscosity curve (viscosity profile) that helps the clinician predict and manage the patient's vulnerability to thrombosis and embolism, which is of particular relevance to COVID-19 patients and/or ICU patients.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Abstract: An analysis, measurement, and data reduction system for carrying out a noninvasive urodynamic analysis of the human male or female urogenital tract. The apparatus comprises a urethral extender device, a vacuum system, a flow and pressure measuring and control system, a parameter variation device, and a control, acquisition and analysis system capable of the analysis of time dependent urine pressure and flow data so as to obtain clinically significant parameters, including bladder pressure and resistance and compliance parameters for the components of the urogenital tract.

Abstract: A clinical whole blood viscometer and a method for obtaining instantaneous whole blood viscosity measurements over a wide range of shear rates with a single blood sample is described. A conventionally acquired sample of fresh blood is drawn from a patient and introduced into the viscometer so as to establish viscous flow, the viscosity measurements being taken by remote sensing devices activated by compliant solids or gases in contact with the sample.